BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 36121543)

  • 1. Systemic Sclerosis Association with Malignancy.
    Lepri G; Catalano M; Bellando-Randone S; Pillozzi S; Giommoni E; Giorgione R; Botteri C; Matucci-Cerinic M; Antonuzzo L; Guiducci S
    Clin Rev Allergy Immunol; 2022 Dec; 63(3):398-416. PubMed ID: 36121543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study.
    Lopez L; Barnetche T; Galli G; Seneschal J; Blanchard E; Shipley E; Pellegrin JL; Lazaro E; Constans J; Duffau P; Schaeverbeke T; Richez C; Kostine M; Truchetet ME
    Joint Bone Spine; 2023 May; 90(3):105555. PubMed ID: 36842760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature.
    Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Vacchi C; Spagnolo P; Cerri S; Luppi F; Richeldi L; Ferri C
    Autoimmun Rev; 2013 Jan; 12(3):374-9. PubMed ID: 22743031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors.
    Maria ATJ; Partouche L; Goulabchand R; Rivière S; Rozier P; Bourgier C; Le Quellec A; Morel J; Noël D; Guilpain P
    Front Immunol; 2018; 9():3112. PubMed ID: 30687318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis.
    Lazzaroni MG; Campochiaro C; Bertoldo E; De Luca G; Caimmi C; Tincani A; Franceschini F; Airò P
    Clin Exp Rheumatol; 2021; 39 Suppl 131(4):25-28. PubMed ID: 33337991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.
    Saigusa R; Asano Y; Nakamura K; Miura S; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Noda S; Aozasa N; Akamata K; Sumida H; Miyazaki M; Tamaki Z; Yanaba K; Kuwano Y; Sato S
    J Dermatol; 2015 May; 42(5):524-7. PubMed ID: 25720827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
    Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
    Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between autoantibodies in systemic sclerosis and cancer in a national registry.
    Hoa S; Lazizi S; Baron M; Wang M; Fritzler MJ; Hudson M;
    Rheumatology (Oxford); 2022 Jul; 61(7):2905-2914. PubMed ID: 34599801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
    Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
    Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
    Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosis.
    Campochiaro C; Lytton S; Nihtyanova S; Fuchs D; Ong VH; Denton CP
    Clin Immunol; 2019 Feb; 199():18-24. PubMed ID: 30771500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
    Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
    J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
    D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
    Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in systemic sclerosis: identifying risk and managing high-risk patients.
    Fragoulis GE; Daoussis D; Pagkopoulou E; Garyfallos A; Kitas GD; Dimitroulas T
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1105-1113. PubMed ID: 33150792
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
    Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
    Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for malignancy in systemic sclerosis patients.
    Kaşifoğlu T; Yaşar Bilge Ş; Yıldız F; Özen G; Pehlivan Y; Yılmaz N; Tarhan F; Yılmaz S; Küçük A; Emmungil H; Koca SS; Çınar M; Direskeneli H; Erken E; Can G; Özmen M; Gönüllü E; Kisacik B; Aksu K; Karadağ O; Kasifoglu N; Arslantas D; Sahin F; Keser G; Yavuz S; Birlik M; Onat AM
    Clin Rheumatol; 2016 Jun; 35(6):1529-33. PubMed ID: 27118199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
    Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
    Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune and inflammatory pathologies associated with systemic scleroderma: Clinical, serological and prognostic profiles. Bi-centric retrospective series in the PACA region].
    Hübsch T; Mettler C; Poisnel E; Antoine C; Cambon A; Delarbre D; Dutasta F; Karkowski L; Pangnarind V; Paris JF; Defuentes G; Granel-Rey B
    Rev Med Interne; 2023 Aug; 44(8):402-409. PubMed ID: 37100631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.